Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block.

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Translational Lung Cancer Research
DOIs	https://doi.org/10.21037/tlcr-20-715
Publication status	Published - 1 Sept 2021

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e838185c13bc454584d6ac29662a31fa,

title = "Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block.",

author = "K Hockenhull and A Ortega-Franco and R Califano",

year = "2021",

month = sep,

day = "1",

doi = "10.21037/tlcr-20-715",

language = "Undefined",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block.

AU - Hockenhull, K

AU - Ortega-Franco, A

AU - Califano, R

PY - 2021/9/1

Y1 - 2021/9/1

UR - https://europepmc.org/articles/PMC8512467

U2 - 10.21037/tlcr-20-715

DO - 10.21037/tlcr-20-715

M3 - Article

C2 - 34733633

SN - 2218-6751

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

ER -